T1	SectionAnnotate 414 457	Patient Identification and Oncology History
T2	SectionAnnotate 3675 3692	Review of Systems
T3	SectionSkip 3946 4037	Allergies as of 05/12/2019  Review Complete On: 05/12/2019 By: ***** ***** *****   No Known
T4	SectionSkip 4054 4073	Current Medications
T5	SectionSkip 4075 5506	Current Outpatient Medications   Medication Sig Dispense Refill    acetaminophen (TYLENOL EXTRA STRENGTH) 500 mg tablet Take 500 mg by mouth every 6 (six) hours as needed for Pain.      bimatoprost (LUMIGAN) 0.01 % DROPSOLN Place 1 drop into both eyes Daily.        calcium-vitamin D 500-125 mg-unit tablet Take 1 tablet (500 mg total) by mouth Daily.      cholecalciferol, vitamin D3, (VITAMIN D3) 2,000 unit TAB Take 1 tablet by mouth Daily.        dorzolamide (TRUSOPT) 2 % ophthalmic solution Place 1 drop into both eyes nightly at bedtime.       multivitamin (THERAGRAN) per tablet Take 1 tablet by mouth.        polyethylene glycol (MIRALAX) 17 gram packet Take 1 packet (17 g total) by mouth daily as needed (constipation). 527 g 0    prochlorperazine (COMPAZINE) 10 mg tablet Take 5 mg by mouth every 6 (six) hours as needed for Nausea.      senna (SENOKOT) 8.6 mg tablet Take 1 tablet by mouth Daily.      traMADol (ULTRAM) 50 mg tablet Take 1 tablet (50 mg total) by mouth Every 4 hours. 40 tablet 1    omeprazole (PRILOSEC) 40 mg capsule Take 1 capsule (40 mg total) by mouth every morning before breakfast. (Patient not taking: Reported on 03/17/2019) 90 capsule 1     Current Facility-Administered Medications   Medication Dose Route Frequency Provider Last Rate Last Dose    influenza vaccine (age >/= 6 months) (PF) (FLUVAVAL, FLUZONE, FLUARIX) injection 0.5 mL  0.5 mL Intramuscular Once ***** *****, MD
T6	SectionSkip 5515 5528	Physical Exam
T7	SectionSkip 8405 10439	FINDINGS: Visualized lung bases:  For chest findings, please see the separately dictated report from the CT of the chest of the same date. Liver:  Mild intrahepatic biliary ductal dilatation and pneumobilia, stable. Gallbladder: Unchanged position of biliary stent. Gallbladder is unremarkable. Spleen:  Unremarkable Pancreas: Slight improvement in pancreatic ductal dilatation, currently measuring 9 mm (series 14 image 37), previously measuring 12 mm. Ill-defined pancreatic mass not clearly seen. Unchanged appearance of bilobed hypoattenuating cystic lesion in the anterior pancreatic head measuring 8 mm which can represent a sidebranch IPMN (series 14 image 50). Adrenal Glands:  Unremarkable Kidneys:  Similar appearance of left kidney interpolar exophytic 1.1 x 1 cm lesion which is hypodense on noncontrast imaging and hyperenhancing on postcontrast images (series 14 image 31). Right kidney interpole simple cyst measuring 1.5 x 1.1 cm, unchanged. GI Tract:  Diverticulosis of the sigmoid colon. Vasculature:  Stable in size mildly prominent subcentimeter periportal and peripancreatic lymph nodes measuring up to 0.7 cm in short axis. Lymphadenopathy: Absent Peritoneum: Unchanged pelvic free fluid. Bladder: Unremarkable Reproductive organs: Unremarkable Bones:  No suspicious lesions Extraperitoneal soft tissues: Unremarkable Lines/drains/medical devices: Biliary stent as 
 above. RADIATION DOSE INDICATORS: Exposure Events: 7 , CTDIvol Max: 5.1 mGy, DLP: 628.9 mGy.cm. The following accession numbers are related to this dose report *****,*****,*****     1. Compared to 03/13/2019, the ill-defined pancreatic mass is no longer seen, likely related to treatment. Interval decrease in pancreatic duct dilation. No evidence of metastatic disease. 2. 1.1 cm left renal enhancing lesion concerning for renal cell carcinoma. Report dictated by: ***** *****, MD, signed by: ***** *****-***** *****, MD Department of Radiology and Biomedical Imaging    Ct Chest With Contrast    Result Date: 05/08/2019  CT CHEST WITH CONTRAST
T8	SectionAnnotate 12208 12225	ASSESSMENT & PLAN
T9	PROBLEM 289 314	pancreatic adenocarcinoma
T10	ClinicalCondition 606 631	pancreatic adenocarcinoma
T11	PROBLEM 695 712	painless jaundice
T12	PROBLEM 717 733	15lb weight loss
T13	TEST 770 774	labs
T14	TEST 787 794	a Tbili
T15	TEST 804 807	AST
T16	TEST 813 816	ALT
T17	TEST 822 830	Alk phos
T18	TEST 849 866	CT abdomen/pelvis
T19	PROBLEM 868 905	intra/extrahepatic biliary dilatation
T20	PROBLEM 922 961	transition point in the pancreatic head
T21	PROBLEM 964 997	9x7mm mass in the pancreatic head
T22	PROBLEM 999 1024	8mm periportal lymph node
T23	TEST 1074 1086	planned ERCP
T24	TEST 1110 1119	CTA chest
T25	RadPathResult 1134 1136	PE
T26	ProcedureName 1144 1148	ERCP
T27	TEST 1160 1165	Tbili
T28	PROBLEM 1185 1231	high grade obstruction in the distal bile duct
T29	TREATMENT 1247 1262	a pigtail stent
T30	TEST 1265 1274	Brushings
T31	PROBLEM 1276 1301	pancreatic adenocarcinoma
T32	TEST 1306 1317	MMR testing
T33	TEST 1353 1358	Tbili
T34	MedicationName 1370 1373	IVF
T35	ClinicalCondition 1378 1401	orthostatic hypotension
T36	Symptom 1441 1457	syncopal episode
T37	ClinicalCondition 1465 1488	orthostatic hypotension
T38	MedicationName 1505 1508	IVF
T39	TEST 1535 1539	Labs
T40	TEST 1553 1559	T bili
T41	TEST 1576 1582	PET/CT
T42	PROBLEM 1601 1644	hypermetabolism in the pancreatic head/neck
T43	PROBLEM 1649 1684	upstream pancreatic ductal dilation
T44	PROBLEM 1690 1709	parenchymal atrophy
T45	PROBLEM 1724 1753	primary pancreatic malignancy
T46	PROBLEM 1755 1767	Primary mass
T47	PROBLEM 1805 1832	a possible hypodense lesion
T48	PROBLEM 1863 1878	hypermetabolism
T49	PROBLEM 1900 1956	Hypermetabolic peripancreatic and periportal lymph nodes
T50	PROBLEM 1972 1992	metastatic 
 disease
T51	TREATMENT 1997 2041	Interval placement of common bile duct stent
T52	PROBLEM 2071 2116	moderate intrahepatic biliary ductal dilation
T53	PROBLEM 2137 2157	Mild hypermetabolism
T54	PROBLEM 2241 2291	Left mid kidney 1.3 cm intermediate density lesion
T55	PROBLEM 2327 2345	a hemorrhagic cyst
T56	PROBLEM 2353 2369	solid renal mass
T57	Radiology 2456 2460	ERCP
T58	PROBLEM 2469 2533	high grade obstruction of the intrapancreatic portion of the CBD
T59	PROBLEM 2539 2556	proximal dilation
T60	TREATMENT 2558 2571	A metal stent
T61	PROBLEM 2590 2603	the stricture
T62	PROBLEM 2634 2647	the stricture
T63	PROBLEM 2653 2673	proximal pneumobilia
T64	TREATMENT 2693 2704	Gemcitabine
T65	Radiology 2717 2723	CT CAP
T66	PROBLEM 2732 2759	stable disease in the liver
T67	PROBLEM 2779 2797	metastatic disease
T68	PROBLEM 2889 2913	potential dental abscess
T69	PROBLEM 2973 2997	periodontal inflammation
T70	PROBLEM 3002 3015	a deep pocket
T71	PROBLEM 3032 3057	her last left lower molar
T72	PROBLEM 3074 3091	a chronic problem
T73	MedicationName 3137 3150	chlorhexidine
T74	TREATMENT 3179 3198	chlorhexidine rinse
T75	PROBLEM 3207 3216	infection
T76	TREATMENT 3248 3260	chemotherapy
T77	TEST 3275 3277	CT
T78	PROBLEM 3290 3317	ill-defined pancreatic mass
T79	TREATMENT 3358 3375	switching regimen
T80	PROBLEM 3452 3469	more gum bleeding
T81	TEST 3471 3487	Her energy level
T82	TREATMENT 3649 3669	small frequent meals
T83	PROBLEM 3935 3955	Allergies  Allergies
T84	PROBLEM 4032 4047	Known Allergies
T85	TREATMENT 4054 4073	Current Medications
T86	TREATMENT 4094 4118	Medications   Medication
T87	TREATMENT 4143 4181	acetaminophen (TYLENOL EXTRA STRENGTH)
T88	PROBLEM 4251 4255	Pain
T89	TREATMENT 4263 4284	bimatoprost (LUMIGAN)
T90	TREATMENT 4344 4361	calcium-vitamin D
T91	TREATMENT 4436 4451	cholecalciferol
T92	TREATMENT 4453 4477	vitamin D3, (VITAMIN D3)
T93	TREATMENT 4531 4552	dorzolamide (TRUSOPT)
T94	TREATMENT 4632 4656	multivitamin (THERAGRAN)
T95	TREATMENT 4700 4729	polyethylene glycol (MIRALAX)
T96	PROBLEM 4798 4810	constipation
T97	TREATMENT 4825 4853	prochlorperazine (COMPAZINE)
T98	PROBLEM 4920 4926	Nausea
T99	TREATMENT 4934 4949	senna (SENOKOT)
T100	TREATMENT 5000 5017	traMADol (ULTRAM)
T101	TREATMENT 5099 5120	omeprazole (PRILOSEC)
T102	TREATMENT 5297 5393	Medications   Medication Dose Route Frequency Provider Last Rate Last Dose    influenza vaccine
T103	TREATMENT 5419 5456	FLUVAVAL, FLUZONE, FLUARIX) injection
T104	TEST 5546 5552	Vitals
T105	TEST 5573 5575	BP
T106	PROBLEM 5597 5611	blurred vision
T107	PROBLEM 5613 5621	headache
T108	PROBLEM 5625 5634	dizzyness
T109	TEST 5638 5643	Pulse
T110	TEST 5650 5654	Resp
T111	TEST 5661 5665	Temp
T112	TEST 5672 5673	C
T113	TEST 5685 5692	TempSrc
T114	TEST 5694 5709	Temporal   SpO2
T115	TEST 5717 5723	Weight
T116	TEST 5750 5756	Height
T117	TEST 5820 5829	Repeat BP
T118	TEST 5838 5842	ECOG
T119	PROBLEM 5867 5878	Symptomatic
T120	PROBLEM 5942 5956	acute distress
T121	PROBLEM 5967 5971	rash
T122	PROBLEM 5973 5980	lesions
T123	PROBLEM 5982 5993	diaphoresis
T124	PROBLEM 5998 6006	jaundice
T125	PROBLEM 6028 6044	anicteric sclera
T126	PROBLEM 6053 6067	Poor dentition
T127	PROBLEM 6075 6087	gum bleeding
T128	PROBLEM 6138 6146	exudates
T129	PROBLEM 6150 6156	thrush
T130	PROBLEM 6174 6215	cervical, supraclavicular lymphadenopathy
T131	TEST 6253 6265	auscultation
T132	PROBLEM 6282 6289	wheezes
T133	PROBLEM 6291 6296	rales
T134	PROBLEM 6300 6307	rhonchi
T135	PROBLEM 6355 6362	murmurs
T136	PROBLEM 6364 6368	rubs
T137	PROBLEM 6373 6380	gallops
T138	PROBLEM 6388 6401	Non-distended
T139	PROBLEM 6433 6443	tenderness
T140	TEST 6447 6456	palpation
T141	PROBLEM 6461 6473	hepatomegaly
T142	PROBLEM 6508 6562	point tenderness at cervical, thoracic or lumbar spine
T143	PROBLEM 6580 6589	BLE edema
T144	PROBLEM 6593 6601	cyanosis
T145	TEST 6821 6841	Alkaline Phosphatase
T146	TEST 6870 6890	Alkaline Phosphatase
T147	TEST 6902 6917	U/L   Bilirubin
T148	TEST 6919 6933	Total   Result
T149	TEST 6944 6949	Range
T150	TEST 6953 6962	Bilirubin
T151	TEST 6964 6969	Total
T152	TEST 6992 7012	Alanine Transaminase
T153	TEST 7022 7027	Value
T154	TEST 7028 7031	Ref
T155	TEST 7032 7037	Range
T156	TEST 7041 7048	Alanine
T157	TEST 7049 7061	transaminase
T158	TEST 7079 7101	Aspartate Transaminase
T159	TEST 7111 7116	Value
T160	TEST 7117 7120	Ref
T161	TEST 7121 7126	Range
T162	TEST 7130 7139	Aspartate
T163	TEST 7140 7152	transaminase
T164	TEST 7170 7180	Creatinine
T165	TEST 7182 7187	Serum
T166	TEST 7190 7205	Plasma   Result
T167	TEST 7206 7211	Value
T168	TEST 7212 7215	Ref
T169	TEST 7216 7221	Range
T170	TEST 7225 7235	Creatinine
T171	TEST 7262 7266	eGFR
T172	TEST 7270 7281	non-African
T173	TEST 7304 7308	eGFR
T174	TEST 7312 7319	African
T175	TEST 7320 7324	Amer
T176	TEST 7347 7358	Blood Count
T177	TEST 7364 7376	Differential
T178	TEST 7386 7391	Value
T179	TEST 7392 7395	Ref
T180	TEST 7396 7401	Range
T181	TEST 7405 7408	WBC
T182	TEST 7409 7414	Count
T183	TEST 7428 7433	x10E9
T184	TEST 7439 7448	RBC Count
T185	TEST 7476 7486	Hemoglobin
T186	TEST 7504 7508	g/dL
T187	TEST 7512 7522	Hematocrit
T188	TEST 7541 7544	MCV
T189	TEST 7563 7566	MCH
T190	TEST 7580 7582	pg
T191	TEST 7586 7590	MCHC
T192	TEST 7604 7608	g/dL
T193	TEST 7612 7626	Platelet Count
T194	TEST 7641 7646	x10E9
T195	TEST 7652 7662	Neutrophil
T196	TEST 7663 7677	Absolute Count
T197	TEST 7693 7698	x10E9
T198	TEST 7704 7718	Lymphocyte Abs
T199	TEST 7719 7722	Cnt
T200	TEST 7729 7730	H
T201	TEST 7742 7747	x10E9
T202	TEST 7753 7765	Monocyte Abs
T203	TEST 7766 7771	Count
T204	TEST 7778 7779	H
T205	TEST 7791 7796	x10E9
T206	TEST 7802 7816	Eosinophil Abs
T207	TEST 7817 7819	Ct
T208	TEST 7837 7842	x10E9
T209	TEST 7848 7860	Basophil Abs
T210	TEST 7861 7866	Count
T211	TEST 7893 7901	Imm Gran
T212	TEST 7903 7913	Left Shift
T213	TEST 7936 7977	Imaging  Ct Abdomen /pelvis With Contrast
T214	TEST 8006 8037	CT ABDOMEN/PELVIS WITH CONTRAST
T215	PROBLEM 8091 8108	pancreatic cancer
T216	TREATMENT 8122 8131	treatment
T217	TEST 8139 8153	restaging scan
T218	TEST 8167 8184	CT abdomen pelvis
T219	TEST 8264 8307	contiguous 1.25-mm collimation axial images
T220	TEST 8354 8384	Coronal and sagittal reformats
T221	TEST 8443 8457	chest findings
T222	TEST 8506 8525	the CT of the chest
T223	PROBLEM 8552 8595	Mild intrahepatic biliary ductal dilatation
T224	PROBLEM 8600 8611	pneumobilia
T225	TREATMENT 8656 8669	biliary stent
T226	PROBLEM 8754 8782	pancreatic ductal dilatation
T227	PROBLEM 8859 8886	Ill-defined pancreatic mass
T228	PROBLEM 8929 8998	bilobed hypoattenuating cystic lesion in the anterior pancreatic head
T229	PROBLEM 9034 9051	a sidebranch IPMN
T230	PROBLEM 9136 9186	left kidney interpolar exophytic 1.1 x 1 cm lesion
T231	PROBLEM 9196 9205	hypodense
T232	TEST 9209 9228	noncontrast imaging
T233	TEST 9251 9270	postcontrast images
T234	PROBLEM 9293 9327	Right kidney interpole simple cyst
T235	PROBLEM 9374 9409	Diverticulosis of the sigmoid colon
T236	PROBLEM 9440 9512	mildly prominent subcentimeter periportal and peripancreatic lymph nodes
T237	PROBLEM 9551 9566	Lymphadenopathy
T238	PROBLEM 9587 9614	Unchanged pelvic free fluid
T239	PROBLEM 9683 9701	suspicious lesions
T240	PROBLEM 9702 9730	Extraperitoneal soft tissues
T241	TREATMENT 9732 9757	Unremarkable Lines/drains
T242	TREATMENT 9758 9773	medical devices
T243	TREATMENT 9775 9788	Biliary stent
T244	TEST 9849 9860	CTDIvol Max
T245	TEST 9871 9874	DLP
T246	PROBLEM 10003 10034	the ill-defined pancreatic mass
T247	TREATMENT 10072 10081	treatment
T248	PROBLEM 10083 10128	Interval decrease in pancreatic duct dilation
T249	PROBLEM 10145 10163	metastatic disease
T250	PROBLEM 10168 10202	1.1 cm left renal enhancing lesion
T251	PROBLEM 10218 10238	renal cell carcinoma
T252	TEST 10344 10374	Biomedical Imaging    Ct Chest
T253	TEST 10417 10419	CT
T254	PROBLEM 10467 10484	pancreatic cancer
T255	TREATMENT 10498 10507	treatment
T256	TEST 10515 10529	restaging scan
T257	PROBLEM 10538 10555	pancreatic cancer
T258	TREATMENT 10569 10578	treatment
T259	TEST 10586 10600	restaging scan
T260	TEST 10613 10628	Multiple priors
T261	TEST 10667 10712	Serial 1.25 mm axial images through the chest
T262	TREATMENT 10755 10775	intravenous contrast
T263	TEST 10847 10858	CTDIvol Max
T264	TEST 10869 10872	DLP
T265	PROBLEM 10987 11003	new lung nodules
T266	PROBLEM 11005 11043	A few scattered sub-3 mm solid nodules
T267	TEST 11070 11092	multiple remote priors
T268	PROBLEM 11094 11156	16mm mixed solid and groundglass nodule in the left upper lobe
T269	PROBLEM 11184 11212	a 3 mm soft tissue component
T270	PROBLEM 11218 11250	adjacent 7 mm groundglass nodule
T271	PROBLEM 11346 11375	intrathoracic lymphadenopathy
T272	PROBLEM 11398 11418	Unchanged heart size
T273	PROBLEM 11423 11443	pericardial effusion
T274	PROBLEM 11527 11571	new bone or soft tissue lesions in the chest
T275	TEST 11601 11632	dedicated Abdomen and Pelvis CT
T276	PROBLEM 11651 11663	new findings
T277	PROBLEM 11675 11707	intrathoracic metastatic disease
T278	PROBLEM 11712 11748	2 subsolid left 
 upper lobe nodules
T279	PROBLEM 11766 11801	primary lung adenocarcinoma lesions
T280	PROBLEM 11827 11845	The largest nodule
T281	PROBLEM 11860 11882	a 3 mm solid component
T282	ClinicalCondition 12026 12049	Pancreatic cancer (HCC)
T283	PROBLEM 12136 12145	Stage IIB
T284	ClinicalCondition 12397 12422	pancreatic adenocarcinoma
T285	ClinicalCondition 12443 12456	comorbidities
T286	TreatmentType 12500 12518	surgical resection
T287	TREATMENT 12546 12555	treatment
T288	TreatmentType 12573 12589	systemic therapy
T289	PROBLEM 12612 12635	palliating any symptoms
T290	TREATMENT 12774 12788	this treatment
T291	TREATMENT 12842 12878	dose reduced gemcitabine monotherapy
T292	PROBLEM 12990 13014	potential dental abscess
T293	TreatmentType 13082 13094	chemotherapy
T294	TEST 13107 13116	Her scans
T295	PROBLEM 13150 13181	the ill-defined pancreatic mass
T296	TreatmentType 13219 13228	treatment
T297	PROBLEM 13230 13275	Interval decrease in pancreatic duct dilation
T299	PROBLEM 13331 13367	a 1.1 cm left renal enhancing lesion
T300	PROBLEM 13383 13403	renal cell carcinoma
T301	PROBLEM 13405 13439	2 subsolid left upper lobe nodules
T302	PROBLEM 13457 13492	primary lung adenocarcinoma lesions
T303	PROBLEM 13494 13512	The largest nodule
T304	PROBLEM 13527 13549	a 3 mm solid component
T305	TEST 13577 13588	these scans
T306	PROBLEM 13679 13700	the pancreatic cancer
T307	PROBLEM 13763 13779	the renal lesion
T308	PROBLEM 13784 13801	pulmonary nodules
T309	TREATMENT 13836 13859	gemcitabine monotherapy
T310	TREATMENT 13882 13907	alternating week schedule
T311	TEST 13960 13982	monthly CA 19-9 levels
T312	TEST 13987 14017	restaging CT cap with contrast
T313	TEST 14080 14085	scans
T314	ClinicalCondition 14121 14134	Left gum pain
T315	Symptom 14139 14147	bleeding
T316	ClinicalCondition 14186 14195	infection
T317	TEST 14240 14260	continued monitoring
T318	MedicationName 14280 14300	chlorhexidine rinses
T319	MedicationName 14327 14344	Influenza vaccine
T320	MedicationName 14438 14446	sennokot
T321	MedicationName 14529 14540	antiemetics
T322	PROBLEM 14765 14781	any new symptoms
T323	PROBLEM 14974 14986	the symptoms
T324	TREATMENT 14988 15002	treatment plan
T325	Age 476 478	86
T327	Histology 617 631	adenocarcinoma
T328	Symptom 695 712	painless jaundice
A3	IsPresentOnFirstCancerDiagnosis T328 yes
A4	IsCausedByDiagnosedCancer T328 yes
A5	ChronicVal T328 non-chronic
A6	ContinuityVal T328 new
T329	Symptom 722 733	weight loss
A7	IsPresentOnFirstCancerDiagnosis T329 yes
A8	IsCausedByDiagnosedCancer T329 yes
A9	ChronicVal T329 non-chronic
A10	ContinuityVal T329 new
T330	Radiology 849 866	CT abdomen/pelvis
A11	IntentVal T330 diagnosis
T331	Radiology 1110 1119	CTA chest
A12	IntentVal T331 diagnosis
A14	IntentVal T57 diagnosis
A1	ChronicVal T10 non-chronic
A2	IntentVal T26 diagnosis
A16	TreatmentTypeVal T26 others
A17	TreatmentCategory T26 Others
A18	IsTumorRemaining T26 yes
T326	ProcedureName 1234 1262	Placement of a pigtail stent
A19	IntentVal T326 others
A20	TreatmentTypeVal T326 others
A21	TreatmentCategory T326 Others
A22	IsTumorRemaining T326 yes
T334	ProcedureName 1265 1274	Brushings
A23	IntentVal T334 diagnosis
A24	TreatmentTypeVal T334 others
A25	TreatmentCategory T334 Others
A26	IsTumorRemaining T334 yes
T335	Datetime 839 847	12/02/18
T336	RadPathResult 887 905	biliary dilatation
A27	RadPathResultVal T336 Others
T337	RadPathResult 922 938	transition point
A28	RadPathResultVal T337 Others
T338	RadPathResult 970 974	mass
A29	RadPathResultVal T338 Others
T339	Site 868 886	intra/extrahepatic
T340	Site 946 961	pancreatic head
T341	Site 982 997	pancreatic head
T342	Site 1003 1013	periportal
T343	LymphNodeInvolvement 1014 1024	lymph node
A30	NegationModalityVal T343 uncertain_in_present
R1	SiteOf Arg1:T342 Arg2:T343	
R2	SiteOf Arg1:T341 Arg2:T338	
R3	SiteOf Arg1:T340 Arg2:T337	
R4	SiteOf Arg1:T339 Arg2:T336	
R5	HappensAtOnDuring Arg1:T335 Arg2:T330	
R6	ResultOfTest Desc:T336 Test:T330	
R7	ResultOfTest Desc:T337 Test:T330	
R8	ResultOfTest Desc:T338 Test:T330	
R9	TestOrProcedureReveals Test:T330 Desc:T343	
T344	Datetime 1027 1035	12/12/18
T345	Datetime 1149 1157	12/13/18
T346	Datetime 2398 2406	01/31/19
T333	SectionSkip 1576 1982;1985 2394	PET/CT: 1. Focal area of hypermetabolism in the pancreatic head/neck and upstream pancreatic ductal dilation with parenchymal atrophy suggestive of primary pancreatic malignancy. Primary mass is not definitely visualized, though a possible hypodense lesion corresponding to this area of hypermetabolism measures 1.1 cm.  2. Hypermetabolic peripancreatic and periportal lymph nodes concerning for metastatic disease. 3. Interval placement of common bile duct stent with interval improvement in moderate intrahepatic biliary ductal dilation, previously severe. Mild hypermetabolism surrounding the common bile duct may be postprocedural. Attention on follow-up. 4. Left mid kidney 1.3 cm intermediate density lesion is indeterminate and may represent a hemorrhagic cyst versus solid renal mass. Attention on follow-up.
A15	SectionSkipType T333 radiology_report
A13	NegationModalityVal T25 negated
R10	ResultOfTest Desc:T25 Test:T331	
T332	Site 907 910	CBD
T347	Size 911 915	22mm
R11	SiteOf Arg1:T332 Arg2:T347	
T348	Datetime 638 651	November 2018
R12	HappensAtOnDuring Arg1:T348 Arg2:T328	
R13	HappensAtOnDuring Arg1:T348 Arg2:T329	
T349	Symptom 1037 1047	syncopized
A31	IsPresentOnFirstCancerDiagnosis T349 no
A32	IsCausedByDiagnosedCancer T349 no
A33	ChronicVal T349 non-chronic
A34	ContinuityVal T349 new
R14	HappensAtOnDuring Arg1:T344 Arg2:T349	
T350	ProcedureName 1082 1086	ERCP
A35	NegationModalityVal T350 negated
A36	IntentVal T350 others
A37	TreatmentTypeVal T350 others
A38	TreatmentCategory T350 Others
R15	NotUndergoneBecauseOf Arg1:T350 Reason:T349	
R16	HappensAtOnDuring Arg1:T345 Arg2:T26	
T351	RadPathResult 1185 1207	high grade obstruction
A39	RadPathResultVal T351 Others
T352	Site 1215 1231	distal bile duct
R17	SiteOf Arg1:T352 Arg2:T351	
R18	ResultOfTest Desc:T351 Test:T26	
R19	ResultOfTest Desc:T351 Test:T326	
T353	ClinicalCondition 1276 1301	pancreatic adenocarcinoma
A40	ChronicVal T353 non-chronic
T354	Histology 1287 1301	adenocarcinoma
A41	EpisodeDescription T354 FirstOccurrence
R20	TumorDesc TumorDetails:T354 Desc:T353	
R21	TestOrProcedureReveals Test:T334 Desc:T353	
T355	Pathology 1306 1317	MMR testing
A42	NegationModalityVal T355 negated
T356	Datetime 1336 1347	December 16
A43	TreatmentContinuityVal T34 finished
A44	TreatmentTypeVal T34 others
A45	TreatmentIntentVal T34 others
A46	TreatmentCategory T34 Supportive
A47	ChronicVal T35 non-chronic
A48	ContinuityVal T35 new
R22	TreatmentAdministeredForProblem Treatment:T34 Prob:T35	
R23	HappensAtOnDuring Arg1:T356 Arg2:T34	
T357	Datetime 1404 1412	12/22/18
A49	IsPresentOnFirstCancerDiagnosis T36 no
A50	IsCausedByDiagnosedCancer T36 no
A51	ChronicVal T36 non-chronic
A52	ContinuityVal T36 stable
A53	ChronicVal T37 non-chronic
A54	ContinuityVal T37 stable
R24	ConditionOrTreatmentCausesProblem Treatment:T37 Prob:T36	
R25	HappensAtOnDuring Arg1:T357 Arg2:T36	
A55	TreatmentContinuityVal T38 finished
A56	TreatmentTypeVal T38 others
A57	TreatmentIntentVal T38 others
A58	TreatmentCategory T38 Supportive
R26	TreatmentAdministeredForProblem Treatment:T38 Prob:T36	
T360	Datetime 2446 2454	03/08/19
R27	HappensAtOnDuring Arg1:T360 Arg2:T57	
T361	RadPathResult 2469 2491	high grade obstruction
A59	RadPathResultVal T361 Others
T362	Site 2499 2533	intrapancreatic portion of the CBD
T363	RadPathResult 2539 2556	proximal dilation
A60	RadPathResultVal T363 Others
R28	SiteOf Arg1:T362 Arg2:T361	
R29	SiteOf Arg1:T362 Arg2:T363	
R30	ResultOfTest Desc:T361 Test:T57	
T364	ProcedureName 2560 2582	metal stent was placed
A61	IntentVal T364 others
A62	TreatmentTypeVal T364 others
A63	TreatmentCategory T364 Others
T366	ClinicalCondition 2653 2673	proximal pneumobilia
T365	ClinicalCondition 2590 2603	the stricture
A64	ChronicVal T365 non-chronic
A65	ChronicVal T366 non-chronic
R31	TestOrProcedureConductedForProblem Test:T364 Prob:T365	
R32	TestOrProcedureConductedForProblem Test:T364 Prob:T366	
R33	TestOrProcedureReveals Test:T57 Desc:T365	
R34	TestOrProcedureReveals Test:T57 Desc:T366	
T367	ClinicalCondition 2634 2647	the stricture
A66	ChronicVal T367 non-chronic
T368	Cycles 2688 2692	C1D1
T369	Cycles 2809 2813	C1D8
T370	Cycles 2826 2831	C1D15
T371	Cycles 2843 2847	C2D1
T372	Cycles 2858 2862	C2D8
T374	Datetime 2678 2686	03/09/19
T375	Datetime 2707 2715	03/13/19
T376	Datetime 2799 2807	03/28/19
T377	Datetime 2815 2823	04/04/19
T378	Datetime 2833 2841	04/18/19
T379	Datetime 2848 2856	04/25/19
T380	Datetime 2915 2923	04/26/19
T381	Datetime 3265 3273	05/08/19
T373	MedicationName 2693 2704	Gemcitabine
A71	IntentVal T65 TreatmentAssessment
T382	DiseaseState 2732 2759	stable disease in the liver
A72	DiseaseStateVal T382 stability
T383	Metastasis 2779 2797	metastatic disease
A73	NegationModalityVal T383 negated
R35	TestOrProcedureReveals Test:T65 Desc:T382	
R36	TestOrProcedureReveals Test:T65 Desc:T383	
R37	HappensAtOnDuring Arg1:T376 Arg2:T369	
R38	HappensAtOnDuring Arg1:T377 Arg2:T370	
R39	HappensAtOnDuring Arg1:T378 Arg2:T371	
R40	HappensAtOnDuring Arg1:T379 Arg2:T372	
R41	TreatmentDesc Therapy:T373 Desc:T369	
R42	TreatmentDesc Therapy:T373 Desc:T370	
R43	TreatmentDesc Therapy:T373 Desc:T368	
R44	HappensAtOnDuring Arg1:T374 Arg2:T368	
R45	TreatmentDesc Therapy:T373 Desc:T371	
R46	TreatmentDesc Therapy:T373 Desc:T372	
A74	NegationModalityVal T372 negated
T384	ClinicalCondition 2899 2913	dental abscess
A75	NegationModalityVal T384 uncertain_in_present
A76	ChronicVal T384 non-chronic
A77	ContinuityVal T384 new
R47	ExclusionCriteriaFor Arg1:T384 Arg2:T373	
R48	NotUndergoneBecauseOf Arg1:T373 Reason:T384	
T385	ClinicalCondition 2973 2997;3004 3015	periodontal inflammation deep pocket
A78	ChronicVal T385 chronic
A79	ContinuityVal T385 worsening
T386	Site 3036 3040;3046 3057	last lower molar
T387	Laterality 3041 3045	left
R49	LateralityOfSite Arg1:T387 Arg2:T386	
R50	SiteOf Arg1:T386 Arg2:T385	
R51	HappensAtOnDuring Arg1:T380 Arg2:T385	
T388	ProcedureName 3101 3131	Tooth was irrigated and rinsed
A80	IntentVal T388 others
A81	TreatmentTypeVal T388 others
A82	TreatmentCategory T388 Others
A83	TreatmentContinuityVal T73 continuing
A84	TreatmentTypeVal T73 others
A85	TreatmentIntentVal T73 others
A86	TreatmentCategory T73 Others
R52	TestOrProcedureConductedForProblem Test:T388 Prob:T385	
R53	TreatmentAdministeredForProblem Treatment:T73 Prob:T385	
T389	MedicationName 3179 3198	chlorhexidine rinse
A87	TreatmentContinuityVal T389 continuing
A88	TreatmentTypeVal T389 others
A89	TreatmentIntentVal T389 others
A90	TreatmentCategory T389 Others
T390	Frequency 3199 3202	BID
R54	Temporal Arg1:T390 Arg2:T389	
T391	ClinicalCondition 3207 3216	infection
A91	NegationModalityVal T391 negated
A92	ChronicVal T391 non-chronic
T392	TreatmentType 3248 3260	chemotherapy
A93	TreatmentContinuityVal T392 continuing
A94	TreatmentTypeVal T392 neoadjuvant
A95	TreatmentIntentVal T392 curative
R55	InclusionCriteriaFor Arg1:T391 Arg2:T392	
T393	Radiology 3275 3281	CT CAP
A96	IntentVal T393 TreatmentAssessment
R56	HappensAtOnDuring Arg1:T381 Arg2:T393	
T394	RadPathResult 3290 3301;3313 3317	ill-defined mass
A97	RadPathResultVal T394 TreatmentResponse
T395	Site 3302 3312	pancreatic
R57	SiteOf Arg1:T395 Arg2:T394	
T396	TreatmentDoseModification 3358 3375	switching regimen
T397	Frequency 3385 3402	alternating weeks
R58	Temporal Arg1:T397 Arg2:T396	
R59	TreatmentDesc Therapy:T396 Desc:T373	
T398	Symptom 3457 3469	gum bleeding
A98	IsPresentOnFirstCancerDiagnosis T398 unclear
A99	IsCausedByDiagnosedCancer T398 no
A100	ChronicVal T398 non-chronic
A101	ContinuityVal T398 stopped
T399	Symptom 3475 3487	energy level
A102	IsPresentOnFirstCancerDiagnosis T399 unclear
A103	IsCausedByDiagnosedCancer T399 unclear
A104	ChronicVal T399 non-chronic
A105	ContinuityVal T399 stable
T400	Symptom 3503 3511	appetite
A106	IsPresentOnFirstCancerDiagnosis T400 unclear
A107	IsCausedByDiagnosedCancer T400 unclear
A108	ChronicVal T400 non-chronic
A109	ContinuityVal T400 stable
T401	Symptom 3537 3543	eating
A110	IsPresentOnFirstCancerDiagnosis T401 unclear
A111	IsCausedByDiagnosedCancer T401 unclear
A112	ChronicVal T401 non-chronic
A113	ContinuityVal T401 worsening
T402	Symptom 3563 3569	weight
A114	IsPresentOnFirstCancerDiagnosis T402 unclear
A115	IsCausedByDiagnosedCancer T402 unclear
A116	ChronicVal T402 non-chronic
A117	ContinuityVal T402 worsening
T403	SectionSkip 5530 5879;5882 6711	Vital Signs:    Vitals:    05/12/19 0927   BP: 150/90  Comment: no blurred vision, headache or dizzyness.   Pulse: 94   Resp: 16   Temp: 36.8 C (98.2 F)   TempSrc: Temporal   SpO2: 99%   Weight: 40.5 kg (89 lb 3.2 oz)   Height: 155.9 cm (5' 1.38")  Comment: March 2019@*****   PainSc:  0   Repeat BP 136/68  ECOG Performance Status: 2 - Symptomatic, <50% confined to bed    Constitutional:  Well-developed, no acute distress  Skin: No rash, lesions, diaphoresis, or jaundice.  Eyes: PERRL, EOMI, anicteric sclera.  HENT: Poor dentition but no gum bleeding. Moist mucous membranes, oropharynx clear without exudates or thrush  Lymph Nodes: no cervical, supraclavicular lymphadenopathy  Respiratory:  Good effort, clear to auscultation bilaterally; no wheezes, rales or rhonchi.  Cardiovascular:  Regular rate and rhythm; no murmurs, rubs, or gallops.  GI:  Non-distended, bowel sounds normal, soft, no tenderness to palpation; no hepatomegaly appreciated.  Musculoskeletal: No point tenderness at cervical, thoracic or lumbar spine  Extremities: No BLE edema or cyanosis  Neurologic:  Alert & oriented x 3, CN III-XII intact, ambulates w/o difficulty, December 12 BUE/BLE strength
A118	SectionSkipType T403 physical_exam
T404	SectionSkip 6715 7834;7837 7931	Diagnostic Data  Labs  Results for orders placed or performed during the hospital encounter of 05/02/19   Alkaline Phosphatase   Result Value Ref Range    Alkaline Phosphatase 68 31 - 95 U/L   Bilirubin, Total   Result Value Ref Range    Bilirubin, Total 0.9 0.2 - 1.3 mg/dL   Alanine Transaminase   Result Value Ref Range    Alanine transaminase 20 11 - 50 U/L   Aspartate Transaminase   Result Value Ref Range    Aspartate transaminase 25 17 - 42 U/L   Creatinine, Serum / Plasma   Result Value Ref Range    Creatinine 0.46 0.44 - 1.00 mg/dL    eGFR if non-African American 90 mL/min    eGFR if African Amer 104 mL/min   Complete Blood Count with Differential   Result Value Ref Range    WBC Count 9.1 3.4 - 10 x10E9/L    RBC Count 4.15 4.0 - 5.2 x10E12/L    Hemoglobin 13.0 12.0 - 15.5 g/dL    Hematocrit 37.5 36 - 46 %    MCV 90 80 - 100 fL    MCH 31.3 26 - 34 pg    MCHC 34.7 31 - 36 g/dL    Platelet Count 248 140 - 450 x10E9/L    Neutrophil Absolute Count 3.79 1.8 - 6.8 x10E9/L    Lymphocyte Abs Cnt 4.36 (H) 1.0 - 3.4 x10E9/L    Monocyte Abs Count 0.88 (H) 0.2 - 0.8 x10E9/L    Eosinophil Abs Ct 0.03 0.0 - 0.4 x10E9/L    Basophil Abs Count 0.03 0.0 - 0.1 x10E9/L    Imm Gran, Left Shift 0.02 <0.1 x10E9/L
A119	SectionSkipType T404 laboratory
T405	SectionSkip 7936 9791;9794 11727;11730 12006	Imaging  Ct Abdomen /pelvis With Contrast    Result Date: 05/08/2019  CT ABDOMEN/PELVIS WITH CONTRAST  *****/*****/***** 9:00 AM CLINICAL HISTORY: pt with pancreatic cancer currently on treatment. needs restaging scan COMPARISON:  CT abdomen pelvis 03/13/2019 TECHNIQUE: Following the administration of 150 cc of Omnipaque 350, contiguous 1.25-mm collimation axial images were obtained through the abdomen and pelvis. Coronal and sagittal reformats were also obtained. FINDINGS: Visualized lung bases:  For chest findings, please see the separately dictated report from the CT of the chest of the same date. Liver:  Mild intrahepatic biliary ductal dilatation and pneumobilia, stable. Gallbladder: Unchanged position of biliary stent. Gallbladder is unremarkable. Spleen:  Unremarkable Pancreas: Slight improvement in pancreatic ductal dilatation, currently measuring 9 mm (series 14 image 37), previously measuring 12 mm. Ill-defined pancreatic mass not clearly seen. Unchanged appearance of bilobed hypoattenuating cystic lesion in the anterior pancreatic head measuring 8 mm which can represent a sidebranch IPMN (series 14 image 50). Adrenal Glands:  Unremarkable Kidneys:  Similar appearance of left kidney interpolar exophytic 1.1 x 1 cm lesion which is hypodense on noncontrast imaging and hyperenhancing on postcontrast images (series 14 image 31). Right kidney interpole simple cyst measuring 1.5 x 1.1 cm, unchanged. GI Tract:  Diverticulosis of the sigmoid colon. Vasculature:  Stable in size mildly prominent subcentimeter periportal and peripancreatic lymph nodes measuring up to 0.7 cm in short axis. Lymphadenopathy: Absent Peritoneum: Unchanged pelvic free fluid. Bladder: Unremarkable Reproductive organs: Unremarkable Bones:  No suspicious lesions Extraperitoneal soft tissues: Unremarkable Lines/drains/medical devices: Biliary stent as above. RADIATION DOSE INDICATORS: Exposure Events: 7 , CTDIvol Max: 5.1 mGy, DLP: 628.9 mGy.cm. The following accession numbers are related to this dose report *****,*****,*****     1. Compared to 03/13/2019, the ill-defined pancreatic mass is no longer seen, likely related to treatment. Interval decrease in pancreatic duct dilation. No evidence of metastatic disease. 2. 1.1 cm left renal enhancing lesion concerning for renal cell carcinoma. Report dictated by: ***** *****, MD, signed by: ***** *****-***** *****, MD Department of Radiology and Biomedical Imaging    Ct Chest With Contrast    Result Date: 05/08/2019  CT CHEST WITH CONTRAST CLINICAL HISTORY:  pt with pancreatic cancer currently on treatment. needs restaging scan pt with pancreatic cancer currently on treatment. needs restaging scan COMPARISON: Multiple priors, most recent of 12/26/2018 TECHNIQUE: Serial 1.25 mm axial images through the chest were obtained after the administration of intravenous contrast. RADIATION DOSE INDICATORS: Exposure Events: 7 , CTDIvol Min: 3.5 mGy, CTDIvol Max: 9.3 mGy, DLP: 628.9 mGy.cm. The following accession numbers are related to this dose report *****,*****,***** *****: LUNGS: No new lung nodules. A few scattered sub-3 mm solid nodules are unchanged compared to multiple remote priors. 16mm mixed solid and groundglass nodule in the left upper lobe (image 84, series 20) with a 3 mm soft tissue component, and adjacent 7 mm groundglass nodule in the left upper lobe (image 81) are unchanged. PLEURA: The pleura is normal. MEDIASTINUM: No intrathoracic lymphadenopathy. HEART/GREAT VESSELS: Unchanged heart size. No pericardial effusion. Thoracic aorta and pulmonary artery are unchanged caliber. BONES/SOFT TISSUES: No new bone or soft tissue lesions in the chest. VISIBLE ABDOMEN: Please see dedicated Abdomen and Pelvis CT report.     1. No new findings to suggest intrathoracic metastatic disease. 2. 2 subsolid left upper lobe nodules likely represent primary lung adenocarcinoma lesions as previously described. The largest nodule is 16 mm with a 3 mm solid component. Report dictated by: ***** ***** *****, MD, signed by: ***** ***** *****, MD Department of Radiology and Biomedical Imaging
A120	SectionSkipType T405 radiology_report
A121	ChronicVal T282 non-chronic
A122	ContinuityVal T282 stable
T406	Stage 12142 12145	IIB
A123	EpisodeDescription T406 FirstOccurrence
T407	TNM 12147 12161	cT1c, cN1, cM0
A124	EpisodeDescription T407 FirstOccurrence
T408	Age 12256 12258	86
A125	ChronicVal T284 non-chronic
A126	ContinuityVal T284 stable
A67	ChronicVal T373 non-chronic
A68	ContinuityVal T373 stable
A69	TreatmentContinuityVal T373 continuing
A70	TreatmentTypeVal T373 maintenance
A127	TreatmentIntentVal T373 palliative
A128	TreatmentCategory T373 AntiNeoPlastics
T409	PatientCharacteristics 12438 12441	age
A129	ChronicVal T285 chronic
A130	ContinuityVal T285 stable
A131	TreatmentTypeVal T286 local
A132	TreatmentIntentVal T286 curative
R60	ExclusionCriteriaFor Arg1:T285 Arg2:T286	
R61	ExclusionCriteriaFor Arg1:T409 Arg2:T286	
A133	TreatmentTypeVal T288 maintenance
A134	TreatmentIntentVal T288 palliative
T410	MedicationRegimen 12855 12878	gemcitabine monotherapy
A135	TreatmentContinuityVal T410 continuing
A136	TreatmentTypeVal T410 maintenance
A137	TreatmentIntentVal T410 palliative
T411	TreatmentDoseModification 12842 12854	dose reduced
R62	TreatmentDesc Therapy:T411 Desc:T410	
T412	Datetime 12882 12891	03/09/19.
R63	BeginsOnOrAt Arg1:T412 Arg2:T410	
T413	ClinicalCondition 13000 13014	dental abscess
A138	ChronicVal T413 non-chronic
A139	ContinuityVal T413 stopped
R64	ExclusionCriteriaFor Arg1:T413 Arg2:T410	
A140	TreatmentContinuityVal T293 continuing
A141	TreatmentTypeVal T293 maintenance
A142	TreatmentIntentVal T293 palliative
T414	Radiology 13111 13116	scans
A143	IntentVal T414 TreatmentAssessment
T415	Datetime 13129 13137	05/08/19
R65	HappensAtOnDuring Arg1:T414 Arg2:T415	
T416	RadPathResult 13154 13165;13177 13181	ill-defined mass
A144	RadPathResultVal T416 TreatmentResponse
T417	Site 13166 13176	pancreatic
R66	SiteOf Arg1:T417 Arg2:T416	
R67	ResultOfTest Desc:T416 Test:T414	
T418	DiseaseState 13185 13199	no longer seen
A145	DiseaseStateVal T418 others
A146	TreatmentContinuityVal T296 continuing
A147	TreatmentTypeVal T296 maintenance
A148	TreatmentIntentVal T296 palliative
T298	Metastasis 13292 13302	metastatic
A149	NegationModalityVal T298 negated
R68	TestOrProcedureReveals Test:T414 Desc:T298	
T419	RadPathResult 13251 13275	pancreatic duct dilation
A150	RadPathResultVal T419 Others
R69	ResultOfTest Desc:T419 Test:T414	
T420	Size 13333 13339	1.1 cm
A151	EpisodeDescription T420 Others
T421	RadPathResult 13351 13367	enhancing lesion
A152	RadPathResultVal T421 Others
T422	Site 13345 13350	renal
T423	Laterality 13340 13344	left
R70	LateralityOfSite Arg1:T423 Arg2:T422	
R71	SiteOf Arg1:T422 Arg2:T421	
T424	ClinicalCondition 13383 13403	renal cell carcinoma
A153	NegationModalityVal T424 uncertain_in_present
A154	ChronicVal T424 non-chronic
R72	ResultOfTest Desc:T421 Test:T414	
R73	TestOrProcedureReveals Test:T414 Desc:T424	
T425	ClinicalCondition 13465 13484	lung adenocarcinoma
A155	ChronicVal T425 non-chronic
A156	ContinuityVal T425 unclear
T426	ClinicalCondition 13683 13700	pancreatic cancer
A157	ChronicVal T426 non-chronic
A158	ContinuityVal T426 unclear
T427	RadPathResult 13498 13512	largest nodule
A159	RadPathResultVal T427 Others
T428	RadPathResult 13432 13439	nodules
A160	RadPathResultVal T428 Others
T429	RadPathResult 13767 13779	renal lesion
A161	RadPathResultVal T429 Others
T430	RadPathResult 13784 13801	pulmonary nodules
A162	RadPathResultVal T430 Others
T431	Site 13421 13431	upper lobe
T432	Laterality 13416 13420	left
R74	LateralityOfSite Arg1:T432 Arg2:T431	
R75	SiteOf Arg1:T431 Arg2:T428	
R76	ResultOfTest Desc:T428 Test:T414	
R77	TestOrProcedureReveals Test:T414 Desc:T425	
A163	NegationModalityVal T425 uncertain_in_present
T433	Size 13516 13521	16 mm
A164	EpisodeDescription T433 Others
T434	Size 13529 13533	3 mm
A165	EpisodeDescription T434 Others
R78	SizeOf Arg1:T433 Arg2:T427	
T435	RadPathResult 13534 13549	solid component
R79	SizeOf Arg1:T434 Arg2:T435	
R80	ResultOfTest Desc:T427 Test:T414	
R81	ResultOfTest Desc:T435 Test:T414	
T436	MedicationRegimen 13836 13859	gemcitabine monotherapy
A166	TreatmentContinuityVal T436 continuing
A167	TreatmentTypeVal T436 maintenance
A168	TreatmentIntentVal T436 palliative
T437	TreatmentDoseModification 13882 13907	alternating week schedule
R82	TreatmentDesc Therapy:T436 Desc:T437	
T438	Symptom 13919 13931	tolerability
A169	ContinuityVal T438 unclear
R83	ConditionOrTreatmentCausesProblem Treatment:T436 Prob:T438	
T439	DiagnosticLabTest 13968 13975	CA 19-9
A170	NegationModalityVal T439 planned_in_future
A171	IntentVal T439 TreatmentAssessment
T440	Frequency 13960 13967	monthly
R84	Temporal Arg1:T440 Arg2:T439	
T441	Radiology 13997 14017	CT cap with contrast
A172	IntentVal T441 TreatmentAssessment
T442	Frequency 14018 14032	every 2 months
A173	NegationModalityVal T441 planned_in_future
R85	Temporal Arg1:T442 Arg2:T441	
T443	Radiology 14080 14085	scans
A174	NegationModalityVal T443 planned_in_future
A175	IntentVal T443 TreatmentAssessment
T444	Cycles 14104 14114	this cycle
T445	Datetime 14098 14114	after this cycle
R86	HappensAfter Arg1:T443 Arg2:T445	
A177	ChronicVal T314 non-chronic
A178	ContinuityVal T314 unclear
A179	IsPresentOnFirstCancerDiagnosis T315 no
A180	IsCausedByDiagnosedCancer T315 no
A181	ChronicVal T315 non-chronic
A182	ContinuityVal T315 stopped
A183	NegationModalityVal T316 negated
R87	ExclusionCriteriaFor Arg1:T316 Arg2:T436	
A184	TreatmentContinuityVal T318 continuing
A185	TreatmentTypeVal T318 others
A186	TreatmentIntentVal T318 others
A187	TreatmentCategory T318 Others
R88	TreatmentAdministeredForProblem Treatment:T318 Prob:T314	
R89	TreatmentAdministeredForProblem Treatment:T318 Prob:T315	
R90	TreatmentAdministeredForProblem Treatment:T318 Prob:T316	
A188	NegationModalityVal T319 planned_in_future
A189	TreatmentTypeVal T319 others
A190	TreatmentIntentVal T319 others
A191	TreatmentCategory T319 Others
A192	TreatmentContinuityVal T320 continuing
A193	TreatmentIntentVal T320 others
A194	TreatmentCategory T320 Supportive
T446	Frequency 14447 14463	4 times per week
R91	Temporal Arg1:T446 Arg2:T320	
A195	TreatmentContinuityVal T321 continuing
A196	TreatmentIntentVal T321 others
A197	TreatmentCategory T321 Supportive
T447	Datetime 14638 14646	05/16/19
T449	Size 964 969	9x7mm
R92	SizeOf Arg1:T449 Arg2:T338	
R93	TestOrProcedureReveals Test:T330 Desc:T449	
T450	Size 999 1002	8mm
R94	SizeOf Arg1:T450 Arg2:T343	
R95	HappensAtOnDuring Arg1:T65 Arg2:T375	
T359	Datetime 12124 12134	02/02/2019
R97	HappensAtOnDuring Arg1:T407 Arg2:T359	
R96	HappensAtOnDuring Arg1:T406 Arg2:T359	
T451	Histology 12408 12422	adenocarcinoma
R98	SizeOf Arg1:T420 Arg2:T421	
R99	TestOrProcedureReveals Test:T414 Desc:T420	
R100	TestOrProcedureReveals Test:T414 Desc:T433	
R101	TestOrProcedureReveals Test:T414 Desc:T434	
R102	SiteOf Arg1:T332 Arg2:T336	
R103	HappensAtOnDuring Arg1:T344 Arg2:T331	
R104	SizeOf Arg1:T347 Arg2:T336	
T448	ap_end 14855 14858	me.
T452	ap_start 12208 12218	ASSESSMENT
T453	Datetime 217 227	05/12/2019
T454	hpi_start 414 421	Patient
T455	ClinicalCondition 289 314	pancreatic adenocarcinoma
A198	ChronicVal T455 non-chronic
T358	hpi_end 1560 1563	8.0
T456	Datetime 1566 1574	01/13/19
T457	hpi_start 2398 2399	0
T458	hpi_end 3664 3670	meals.
R105	BeginsOnOrAt Arg1:T356 Arg2:T34	
R106	EndsOnOrAt Arg1:T356 Arg2:T34	
R107	HappensAtOnDuring Arg1:T357 Arg2:T38	
R108	BeginsOnOrAt Arg1:T357 Arg2:T38	
R109	EndsOnOrAt Arg1:T357 Arg2:T38	
R110	BeginsOnOrAt Arg1:T380 Arg2:T73	
R111	EndsOnOrAt Arg1:T380 Arg2:T73	
R112	HappensAtOnDuring Arg1:T380 Arg2:T73	
R113	BeginsOnOrAt Arg1:T380 Arg2:T389	
